Deciphering the roles of triiodothyronine (T3) and thyroid-stimulating hormone (TSH) on cardiac electrical remodeling in clinical and experimental hypothyroidism

J Physiol Biochem. 2024 Feb;80(1):1-9. doi: 10.1007/s13105-023-01000-z. Epub 2023 Nov 29.

Abstract

Hypothyroidism is the most frequent endocrine pathology. Although clinical or overt hypothyroidism has been traditionally associated to low T3 / T4 and high thyrotropin (TSH) circulating levels, other forms exist such as subclinical hypothyroidism, characterized by normal blood T3 / T4 and high TSH. In its different forms is estimated to affect approximately 10% of the population, especially women, in a 5:1 ratio with respect to men. Among its consequences are alterations in cardiac electrical activity, especially in the repolarization phase, which is accompanied by an increased susceptibility to cardiac arrhythmias. Although these alterations have traditionally been attributed to thyroid hormone deficiency, recent studies, both clinical trials and experimental models, demonstrate a fundamental role of TSH in cardiac electrical remodeling. Thus, both metabolic thyroid hormones and TSH regulate cardiac ion channel expression in many and varied ways. This means that the different combinations of hormones that predominate in different types of hypothyroidism (overt, subclinic, primary, central) can generate different forms of cardiac electrical remodeling. These new findings are raising the relevant question of whether serum TSH reference ranges should be redefined.

Keywords: Arrhythmia; Cardiac electrophysiology; Electrical remodeling; Endocrine disease.

Publication types

  • Review

MeSH terms

  • Atrial Remodeling*
  • Female
  • Humans
  • Hypothyroidism*
  • Male
  • Thyrotropin / therapeutic use
  • Thyroxine / therapeutic use
  • Triiodothyronine / therapeutic use

Substances

  • Triiodothyronine
  • Thyrotropin
  • Thyroxine